Menu
Washingtoner
  • Home
  • Boeing
  • Health
  • Aerospace
  • Daryl Guberman
  • Technology
  • ANSI-ANAB
  • Business
  • Manufacturing
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • One Phone Call Is All It Takes to Lose a New Dental Patient — Here Is Why
  • Five-star Review for Berklee School of Music Textbook
  • Melospeech Inc. Awarded New NYSDOH BEI Contract in New York
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • Flint Youth Film Festival Shifts Gears, Becomes Vehicle City Film Festival
  • Celebrate Tacoma's Top Volunteers and Service Providers at the 2026 City of Destiny Awards
  • 62% of Gen X have no estate planning documents — Trust & Will research identifies "the Sandwich Gap"
  • Nayarit's Jungle Coast Redefines Luxury Travel on Mexico's Pacific Now More Accessible Than Ever
  • $10 Million Annual Revenue Merger, Profitable Partner in AI Powered Specialty Automotive Sales Projected to Scale Above $200M: Stock Symbol: NWPG

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • RAS AP Consulting Launches Vendor Master File & Payment Controls Assessment for NACHA Phase 2 Compliance
  • Spokane: 2026 Wildfire & Forestry Safety Fair
  • Spokane AI Expert Adam Chronister to Discuss Authority Engineering at AI Roundtable Event
  • Spokane: Riverfront Park Shuttle Service Opens May 1, Zipline Coming Fall 2026

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • 'Home in Tacoma' Sparks 62% Increase in Number of Proposed Housing Units in First Year
  • Food Journal Magazine Unveils Its Latest 'Best of Los Angeles' Culinary Discoveries
  • Boston Industrial Solutions Launches Natron® 717S Series: A New Flexible UV LED Ink for Ricoh GH2220 Printheads
  • 5 Things NYC Courier Services Won't Tell You About How Same-Day Delivery Actually Works
  • Spokane City Council Votes in Support of Moving Forward the STA Ballot Initiative
  • Tropidelic Links Up With International Reggae Star Collie Buddz and Eli Mac for Feel-Good Breakthrough Single "Follow Your Nature"
  • Save 15 Percent on Florida Keys Accommodations with KeysCaribbean's 'Advance Purchase Rate Discount'
  • Atelier 411 Studios and Columbus Fashion Council Present Red Carpet Experience at Gateway Film Center for The Devil Wears Prada 2
  • Hazel E Celebrates Birthday with Luxury "Goddess" Yacht Experience in Marina del Rey
  • Joseph Neibich sits down with Bold Jounrey (aka Joseph Nybyk)
  • AI Suite 360 Launches Done-For-You AI Implementation to Rescue SMBs from the "Frankenstein Tax"
  • Spokane: Mayor Brown Reestablishes City Arts Office, Names New Manager to Lead Effort
  • CX Network Releases Report on the Best AI Support Tools for SaaS Companies 2026
  • Outlier Pest Season Hits Willamette Valley as Mild Winter Drives Early Surge in Ant and Rodent Activity
  • Lokal Media House Wins Web Excellence Award for Black Plumbing Redesign
  • Lick Expands Flavored Massage Oil Collection with 10 New Indulgent Cream-Inspired Scents
  • New Research Identifies "Vacation Compatibility Gap" as the Hidden Force Shrinking How Long and With Whom Americans Travel
  • Melospeech Inc. Awarded New NYSDOH BEI Contract in New York
  • Five-star Review for Berklee School of Music Textbook
  • One Phone Call Is All It Takes to Lose a New Dental Patient — Here Is Why
_catLbl0 _catLbl1

Popular on Washingtoner

  • Foiling Freaks Launches New Online Platform Dedicated to Foiling Board Sports - 111
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • City of Tacoma Recognized for 39th Consecutive Year with Highest Honor in Governmental Financial Reporting
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Tacoma Police Department’s CALEA Public Comment Portal

Similar on Washingtoner

  • Why Athletic Recovery Begins in the Nervous System
  • Strategic Talent Associates Launches THE ALIGNED RESET™
  • Karen D. Gentry Announces New Book Focused on Relationships and Personal Growth
  • New plusOne Research Finds the Orgasm Gap Is a 30-Point Chasm — and Confirms It Isn't Biology
  • CCHR Report Links 145 Violent Incidents to Psychiatric Drug Exposure, Urges National Oversight and Action
  • CX Network Releases Report on the Best AI Support Tools for SaaS Companies 2026
  • Lick Expands Flavored Massage Oil Collection with 10 New Indulgent Cream-Inspired Scents
  • Advanced TeleSensors Appoints AgeTech Innovator Tiffany Wey, MBA as Vice President of Sales & Marketing
  • Permian Museum Adds Carbonaceous Chondrite Reference Photos
  • CCHR Says New OIG Report Raises Concerns about Drugging Elderly with Antipsychotics
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute